KROS · Keros Therapeutics, Inc. · Exempt Offerings
$10.08
+0.54 (+5.66%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$197.81M
Shares
19.62M
Volume · Nov 12
630.16K
Avg daily vol (3M)
187.94K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
85 filings
70 filers
Visit website
Investor relations